Clover Health Investments (CLOV) Tops Q3 EPS by 4c

Clover Health Investments (NASDAQ: CLOV) reported Q3 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $856.8 million versus the consensus estimate of $804.04 million.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target